Inozyme Pharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Inozyme Pharma's balance sheet done over the years? Its assets were worth $200,847,000 last year, which is more than in the previous period. 30% of Inozyme Pharma’s total assets is currently financed by debt. Its liabilities reached the amount of $60,368,000, which means an increase by 190% compared compared to last year.

Debt to Assets

Inozyme Pharma, Inc. (NASDAQ:INZY): Debt to assets
2018 43543000 57.41M 131.87%
2019 47944000 81.16M 169.29%
2020 169363000 11.26M 6.65%
2021 123541000 14.27M 11.55%
2022 139195000 20.80M 14.94%
2023 200847000 60.36M 30.06%

INZY Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
34.58M32.91M23.31M159.89M31.60M35.96M
Short term investments
154.00M94.95M88.48M119.65M15.52M7.19M
Net receivables
385K115K62K155K104K31K
Inventory
0-115K-62K-12.35M00
Other current assets
7.27M3.52M3.54M3.28M224K73K
Total current assets
196.25M131.39M115.34M150.97M47.46M43.26M
Non-current assets:
Property, Plant and Equipment
2.59M3.63M4.43M2.64M298K242K
Goodwill
000000
Intangible assets
000000
Long term investments
0354K354K12.19M130K0
Other non-current assets
2.00M3.81M3.40M3.53M56K34K
Total non-current assets
4.59M7.80M8.19M18.38M484K276K
Total assets
200.84M139.19M123.54M169.36M47.94M43.54M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
03.81M0279K00
Short term debt
1.82M816K731K-279K00
Total current liabilities
14.68M14.71M11.63M9.97M3.23M2.38M
Non-current liabilities:
Long term debt
45.68M5.96M2.64M1.28M00
Deferred tax
000000
Other non-current liabilities
0124K00055.02M
Total non-current liabilities
45.68M6.08M2.64M1.28M77.92M55.02M
Total liabilities
60.36M20.80M14.27M11.26M81.16M57.41M
Data sourceData sourceData sourceData source